Brought to you by:
Gore completes first-in-human implants of Viafort vascular stent
W. L. Gore today announced the first implants of its investigational Gore Viafort vascular stent as part of a recently initiated pivotal clinical study for the treatment of inferior vena cava (IVC) occlusive disease with or without iliofemoral vein involvement. The…
The top 10 most popular Vascular Specialist stories of September 2022
September’s top stories featured news of a trial to evaluate women’s experience of early endovascular aneurysm repair, and of a special women-focused edition of the Annals of Vascular Surgery. A guest commentary on the importance of advocacy in vascular surgery…
SVS weighs in on 2023 Medicare payment rules for physicians and hospital outpatient services
The Society for Vascular Surgery (SVS) has submitted comment letters in response to the proposed rules issued by the Centers for Medicare and Medicaid Services (CMS) on Medicare Physician Fee Schedule (MPFS) and the Medicare Hospital Outpatient Perspective Payment System…
Registry data highlight long-term trends in hemodialysis access profile of failed kidney transplant patients
New findings, recently published in the Journal of Vascular Access (JVA), provide insight into the hemodialysis access profile of failed kidney transplant patients treated in the Catalonia region of Spain over an 18-year period. Researchers Ramon Roca-Tey, MD, a senior…
Clinical outcomes of the ClotTriever system in DVT set to be evaluated in RCT
Inari Medical has announced planned enrollment of the DEFIANCE randomized controlled trial (RCT), which is designed to compare the clinical outcomes of patients with iliofemoral deep vein thrombosis (DVT) treated with the ClotTriever system versus anticoagulation only. The trial will enroll 300 patients…
The top 10 most popular Vascular Specialist items of June 2022
June’s top stories spanned a range of presentations from the 2022 Vascular Annual Meeting (VAM) in Boston (June 15–18), covering topics including burnout among vascular surgeons, amputation rates in Black and Hispanic CLTI patients, and VAM’s inaugural Women’s Section education…
Six years, much growth and multiple changes to JVS publications
Their terms about to end, Peter Gloviczki, MD, and Peter Lawrence, MD, editor-in-chief and senior editor, respectively, of the Journal of Vascular Surgery family of publications reflect on their time at the helm and the changes they’ve seen—and implemented—along the…
Discussing ERAS—Enhanced Recovery After Surgery
Enhanced Recovery After Surgery (ERAS) pathways have been beneficial for many surgical specialties and are now available to guide the perioperative care of patients undergoing open aortic operations. The Vascular Quality Initiative (VQI) will discuss this important topic starting at…
Wound healing research earns SVS Foundation prize, place on VAM stage
University of Michigan resident and Vascular Specialist resident/fellow editor Christopher Audu, MD, has been granted the SVS Foundation Resident Research Award for 2022. And, already, he is looking ahead to where the research might go next, and the wider importance…
A modest proposal: Let’s eat the trauma surgeons
Well folks, after more than two years of the pandemic, racial injustice, and medical misinformation, I have decided it is time to return to writing about what I truly love: fake feuds with other specialties. Remember the heady days of…